DexCom
DXCM
727 hedge funds and large institutions have $37.8B invested in DexCom in 2020 Q3 according to their latest regulatory filings, with 89 funds opening new positions, 288 increasing their positions, 265 reducing their positions, and 81 closing their positions.
10% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 81
9% more repeat investments, than reductions
Existing positions increased: 288 | Existing positions reduced: 265
7% more call options, than puts
Call options by funds: $584M | Put options by funds: $544M
1% more capital invested
Capital invested by funds: $37.4B → $37.8B (+$401M)
1% more funds holding
Funds holding: 722 → 727 (+5)
15.76% less ownership
Funds ownership: 400.21% → 384.45% (-16%)
41% less funds holding in top 10
Funds holding in top 10: 22 → 13 (-9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sands Capital Management
Arlington,
Virginia
|
+$205M |
| 2 |
Morgan Stanley
New York
|
+$199M |
| 3 |
BlackRock
New York
|
+$68.6M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$65.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$56.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$189M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$167M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$131M |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$78.8M |
| 5 |
Goldman Sachs
New York
|
-$53.1M |
DXCM Hedge Fund Activity: Q3 2020 in Review
727 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2020, worth a combined $37.8B — up 1.1% from $37.4B a quarter earlier.
Buyers outnumbered sellers: 89 funds opened new DXCM positions and 81 closed out — a net gain of 8 holders — while 288 added to existing stakes and 265 trimmed.
The largest buyer was Sands Capital Management, adding an estimated $205M. The largest seller was Renaissance Technologies, cutting an estimated $189M.
- 727 institutional investors held DexCom (DXCM) as of Q3 2020, up from 722 in Q2 2020.
- Funds reported $37.8B of DexCom stock for Q3 2020, up 1.1% quarter-over-quarter.
- 89 funds opened new DexCom positions in Q3 2020 and 81 closed out, a net change of +8 holders.
- The largest DexCom buyer in Q3 2020 was Sands Capital Management, an estimated $205M added.
- The largest DexCom seller in Q3 2020 was Renaissance Technologies, an estimated $189M sold.
Based on aggregated 13F filings for Q3 2020.